Artificial intelligence (AI) is transforming the life sciences industry, with potentially its most significant impact on drug ...

High-resolution analytical platforms, proteomics-driven workflows, and expanding CRO outsourcing reshape strategic priorities ...

This figure illustrates three key applications of AI in antimicrobial drug development: (1) target identification and validation, including novel target discovery, affinity prediction, multi-target ...

AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...

Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.

Baylor College of Medicine will be a site for a new multi-institution project aimed at investigating preclinical drug safety assessments. The project, known as DATAMAP, the Digital Acceleration of ...

In a recent exclusive interview, Fierce Biotech’s Chris Hayden sat down with Alex MacDonald, Vice President of Model-Informed Drug Development at Allucent, to explore the impact of Project Optimus, an ...

Advancements in AI, multi-omics, and genome editing are transforming life sciences and biotechnology, addressing new ...

AlphaFold, a transformative AI-driven tool developed by DeepMind, has revolutionized the field of structural biology by accurately predicting protein structures. This breakthrough holds significant ...

Quantum systems can simulate molecular interactions at a level of fidelity that classical computers cannot achieve. They can ...

This webinar explores how liver microphysiological systems support toxicology from early screening to species-specific risk ...